Current Studies

PLEASE NOTE DUE TO THE CURRENT COVID 19 PANDEMIC OUR RESEARCH WORK IS FOCUSED ON URGENT PUBLIC HEALTH STUDIES LOOKING INTO COVID-19

CURRENT STUDIES LISTED BELOW WILL RESUME AS SOON AS IT IS SAFE TO DO SO:

 

BICS Study: This study is trying to find out if a well established heart drug (Bisoprolol) reduces the number of 'flare- ups' that people living with Chronic Obstructive Pulmonary Disease  Obstructive (COPD) have. https:// w3.abdn.ac.uk/hsru/BICS           



DECIDE Study: This study will help doctors to decide whether dapagliflozin is a suitable long- term treatment for patients with type 2 diabetes who have not been able to achieve good diabetic control on other drugs, when used in real life practice. 

Dapagliflozin is a medication used to treat Type 2 diabetes- the medication works on your kidneys by increasing the amount of sugar removed from your body when you pass urine.

https://www.hra.nhs.uk/planning-and-improving-research/application-summaries/research-summaries/d1690r00009-the-decide-study/


ContactMe-IBS: Is a research register that anyone over 18yrs can sign up, if they are interested in hearing about and taking part in Irritable Bowel Syndrome (IBS) research.

 https://www.contactme-ibs.co.uk/


PROMDEP Study – The study team  would like to see whether giving personal feedback to people with depression, or low mood, can help them to get better more quickly.  If you have attended the surgery for low mood or depression you may be given an information pack by the clinician seeing you, or we may send an information pack out to you. For more information click here

REDUCE Study - The REDUCE study aims to help people on long-term antidepressants reduce the dose of their antidepressant one step at a time, over some weeks or months, and eventually stop taking it altogether if appropriate. This would be led and supported by your GP (or nurse prescriber), and you would have follow-up appointments for support and monitoring for any withdrawal symptoms or recurrence of depression. For more information click here


FRONTIER Study - First Contact Physiotherapy (FCP) is a rapidly developing approach to managing MSKD in primary care, whereby a specialist MSK physiotherapist located within general practice undertakes the first patient assessment, diagnosis and management without the requirement for prior GP consultation.  The study team are investigating the effectiveness and costs associated with First Contact Physiotherapy for Musculoskeletal Disorders in Primary Care. 

http://www.frontierstudy.co.uk/